Post by Myriad Genetics

Thank you to Precision Medicine Online for highlighting the launch of Prolaris® + AI. Prolaris + AI is the first and only #prostatecancer biomarker test to unite clinical-pathological features, an independent molecular score, and independent AI-powered digital pathology technology.₁₋₄ We are thrilled to see this important advancement in prostate cancer care being shared - See the article: https://lnkd.in/e4WhCikm. References: 1. Cuzick J, et al. Lancet Oncol. 2011;12(3):245-255. 2. Cuzick J, et al. Br J Cancer. 2012; 106(6): 1095-1099. 3. Cuzick J, et al. Br J Cancer. 2015; 113(3): 382-389. 4. Mabey B, et al. medRxiv. 2026; [Preprint] doi: https://lnkd.in/d8_QKAh7.